The EIF1AD Antibody (PACO09027) is a highly specific polyclonal antibody designed for research involving the EIF1AD protein, a key regulator of translation initiation. The antibody, generated in rabbits, is highly reactive with human samples and is validated for use in various applications, including Western blotting and immunohistochemistry.EIF1AD plays a crucial role in protein synthesis by promoting the formation of the pre-initiation complex, leading to efficient translation initiation. Dysregulation of EIF1AD has been linked to various diseases, including cancer and neurological disorders, making it a promising target for therapeutic interventions.
This antibody binds specifically to the EIF1AD protein, allowing for precise detection and analysis in different cell types and tissues. Its high specificity and sensitivity make it ideal for studies in molecular biology, cell biology, and cancer research. Understanding the role of EIF1AD in translation regulation is essential for unraveling its impact on cellular processes and disease development.
